Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance, at beginning at Dec. 31, 2017 $ 8 $ 186,983 $ (12) $ (162,363) $ 24,616
Balance, at beginning (in shares) at Dec. 31, 2017 7,830,040        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock related to restricted stock units
Issuance of common stock related to restricted stock units (in shares) 750        
Issuance of common stock under purchase Agreement , net of transaction expenses of $ 1 2,255 2,256
Issuance of common stock under purchase Agreement , net of transaction expenses of (in shares) 1,080,000        
Issuance of common stock under At-the-market offering, net of transaction expenses of $ 1 4,095 4,096
Issuance of common stock under At-the-market offering, net of transaction expenses of (In shares) 1,569,666        
Stock-based compensation   1,259 1,259
Foreign currency translation loss (17) (17)
Net loss (18,501) (18,501)
Balance, at end at Sep. 30, 2018 $ 10 $ 194,592 $ (29) $ (180,864) $ 13,709
Balance, at end (in shares) at Sep. 30, 2018 10,480,456